Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
52 Cards in this Set
- Front
- Back
Who is most at risk for rhabdo after recieving Sch
|
children under 8 yo
|
|
Who is at risk for developing myalgia after Sch
|
men
sedentary people |
|
Who is at low risk for developing myalgia after Sch
|
elderly
children pregnant |
|
When might Sch cause bradycardia? How do we prevent this
|
upon second dose
pretreat with atropine |
|
When will increased IOP onset and resolve in patient receiving Sch
|
4 minutes
5-7 minutes |
|
What does Sch do to intragastric pressure
|
Increases P
Increases LES tone |
|
What does Sch do to serum K
|
increases the serum K by 0.5-1 mEq/L
|
|
What is the safe time to give Schs after burns
|
before 24 hours
after 120 days |
|
Normal dibucaine test
Heterozygous Homozygous |
70-80
50-69 16-30 |
|
4 things that increase plasma cholinesterase
|
obesity
thyrotoxicosis anxiety psychiatric disorders |
|
NMB that cause histamine release
|
Mivacurium
Atracurium Sch |
|
% of twitch height recovery that the patient needs to regain control of upper airway muscles
|
90
|
|
NMB that will be prolonged with renal disease
|
Vec
Pan |
|
NMB that will be prolonged with liver disease
|
everything but atrac and cisatrac
|
|
What AB potentiate NMB
|
mycins
micins |
|
What are 6 drugs that potentiate NMB
|
Volatile anesthetics
Local anesthetics antibiotics anticonvulsants reglan MgSO4 |
|
3 drugs that antagonize nondepolarizing NMB
|
chronic seizure meds
acetylcholinesterase inhibitors succinylcholine |
|
5 conditions that enhance NMB
|
hypothermia
respiratory acidosis decreased K decreased Ca MgSO4 |
|
NMB of choice for burn patients
|
Mivacurium
|
|
What receptors does atracurium act on
|
pre and postsynaptic
|
|
3 problems with atracurium
|
histamine release
laudanosine anaphylaxis |
|
NMB of choice for liver/renal disease
|
cisatracurium
|
|
NMB that is not a good drug for renal or obesity
|
vecuronium
|
|
Who is roc prolonged in
|
liver failure- moderate
elderly pregnancy |
|
Who is pancuronium contraindicated in
|
Cardiac
|
|
What does pancuronium do to CVS
|
increases HR, BP, CO
|
|
Reversal agent for mivacurium
|
edrophonium
|
|
Reversal agent for peds
|
edrophonium
|
|
Reversal agent used most commonly
|
neostigmine
|
|
Carbamyl esters that form a chemical bond
|
neotstigmine
pyridostigmine |
|
Quat ammonium that forms an electrostatic bond
|
edrophonium
|
|
How will you dose neostigmine for children
|
decrease the dose
|
|
Which Achesterase inhibitor has an active metabolite
|
Neostigmine
|
|
Onset and duration of edrophonium
|
1-2 minutes
5-20 minutes |
|
Onset and duration of Neostigmine
|
7-11 minutes
40-60 minutes |
|
Onset and duration of pyridostigmine
|
16
90 minutes |
|
Anticholinergic that doesn't cross the BBB and is used with Neostigmine
|
gylcopyrrolate
|
|
What anticholinergic is used when reversing with edrophonium
|
atropine
|
|
Max dose of neostigmine
|
5 mg/day
|
|
When administering Sch who is most likely to experience bradycardia
|
children
|
|
When administering a second dose of Sch who is most likely to experience bradycardia
|
adults
|
|
What is the dibucaine test for
|
plasma cholinesterase abnormality
|
|
What pharmacokinetic adjustments and expectations will you have with liver failure with non-depolarizing NMB
|
larger loading dose
decreased clearance |
|
What does reglan do to plasma cholinesterase
|
inhibits it
|
|
Metabolizes mivacurium
|
plasma cholinesterase
|
|
Metabolizes atracurium
|
plasma esterases
|
|
What is the atracurium dose after sch
|
0.25
|
|
Good CV drug that is slightly vagotonic
|
vecuronium
|
|
Respiratory condition that could prolong vec
|
hypercarbia
|
|
What is rocuronium's metabolism
|
minimal
excreted unchanged by kidneys and in BILE |
|
NMB with a vagal blockade
|
Pancuronium
|
|
NMB that may cause dysrhythmias when given with digoxin
|
Pacuronium
|